Last Updated:
11:30 am
Wednesday, July 9, 2025
Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. It offers a diagnostic blood test for screening for colorectal cancer under the ColoSTAT brand. The company was founded on June 1, 2017, and is headquartered in Parkville, Australia.
asx-rhy
Market Cap
AU$18.00M
Volume
7500
Open
0.06
AU$
High
0.06
AU$
Low
0.06
AU$
Shares On Issue
256M
52 Week Low
0.042
AU$
52 Week High
0.14
AU$
Website
www.rhythmbio.com
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved